Goodwill (Tables)

6 Months Ended

Jun. 30, 2015

Acquired Finite-Lived Intangible Assets [Line Items]

Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]

The net carrying value of the identifiable intangible assets as of June 30, 2015 is as follows: 

		As of June 30, 2015
	Life	Carrying
	(Years)	Amount
Diagnostic assets:
Asuragen acquisition:
Thyroid	9	$	8,519
Pancreas	7	2,882
Biobank	4	1,575
RedPath acquisition:
Pancreas test	7	16,141
Barrett's test	9	18,351
Total		$	47,468
Diagnostic lab:
CLIA Lab	2.3	$	609
Accumulated Amortization		$	(2,629	)
Net Carrying Value		$	45,448

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Estimated amortization expense for the next five years is as follows:

2015	2016	2017	2018	2019
$3,803	$6,328	$6,097	$5,949	$5,703